Light activation of transcription: photocaging of nucleotides for control over RNA polymerization by Pinheiro, André Vidal et al.
Published online 27 June 2008 Nucleic Acids Research, 2008, Vol. 36, No. 14 e90
doi:10.1093/nar/gkn415
Light activation of transcription: photocaging of
nucleotides for control over RNA polymerization
Andre ´ Vidal Pinheiro
1,2, Pedro Baptista
2,* and Joa ˜o Carlos Lima
1
1REQUIMTE, Departamento de Quı ´mica, Faculdade de Cie ˆncias e Tecnologia, Universidade Nova de Lisboa and
2CIGMH, Departamento Cie ˆncias da Vida, Faculdade de Cie ˆncias e Tecnologia, Universidade Nova de Lisboa,
Campus de Caparica, 2829-516 Caparica, Portugal
Received May 27, 2008; Revised June 12, 2008; Accepted June 16, 2008
ABSTRACT
We describe the use of ATP caged with [7-(diethyl-
amino)coumarin-4-yl]methyl (DEACM) for light-
controlled in vitro transcription reactions.
Polymerization is blocked when DEACM is bonded
to the gamma phosphate group of the ATP mole-
cule. Controlled light irradiation releases ATP and
transcription is initiated. In order to provide full con-
trol over the process, conditions involved in sub-
strate release, nucleotide availability after release
and the effect of the released coumarin in RNA
polymerization were assessed in further detail.
Together, our data provide the first direct evidence
of control over enzymatic polymerization of nucleic
acids through light. This approach may provide
researchers with a unique tool for the study of bio-
logical processes at a molecular level.
INTRODUCTION
Controlled temporal and spatial release of biomolecules
from photolabile precursors, commonly known as caged
molecules, is increasingly becoming an important tool in
biology studies. The rationale of using caged compounds
is straightforward: the molecule of interest is rendered
biologically inactive (caged) by chemical modiﬁcation
with a protecting group that can be removed with light
by irradiation of a suitable wavelength (1,2). This pro-
motes the release of the biologically active molecule, gen-
erating a time-controlled burst in concentration with tight
spatial control (3).
The caged molecule must fulﬁll several critical condi-
tions: (i) the resulting byproducts (after photocleavage),
when used at the chosen concentration, should not facil-
itate or hamper the reaction; (ii) the rate of uncaging must
be faster than the process under study, i.e. the rate at
which the biomolecule is released should not be the rate
limiting step and (iii) the eﬃciency of uncaging should be
high in order to avoid long irradiation times and deleteri-
ous eﬀects to the biological samples. Till now, the choice
of caging agents released by light is still restricted to a
small number of molecules. Most are UV absorbing
molecules with low photocleavage eﬃciencies and small
extinction coeﬃcients, e.g. 2-nitrobenzyl (4,5) and nitro-
phenylalkyl derivatives (6). The hydroxyphenancyl deriva-
tives show enhanced photochemical properties but also
absorb in the UV region (7). Quinoline (8,9) and coumarin
(10–12) derivatives present higher extinction coeﬃcients,
high photochemical quantum yields and absorb in the
visible region (<420nm). Coumarin derivatives also have
the advantage of fast photocleavage kinetics and wave-
length tunability through changes in the position and/or
nature of the chemical residues attached to the coumarin
moiety (3,13). Despite the advantages over the UV absorb-
ing groups, these quinoline or coumarin-based compounds
have generally low water solubility. Strategies to cage vir-
tually any constituent or biomolecule have been proposed
[for a review see refs (14,15) and references therein]. In
particular, caging of nucleotides—ATP and cAMP—has
been applied in living cells for physiologic response
studies, where the unaltered nucleotide is released by UV
or visible irradiation (11,16).
Nucleotides, the natural substrates of DNA and RNA
polymerases, appear like a straightforward application of
the caging technique to DNA and/or RNA enzymatic
synthesis. Utilization of caged nucleotides in nucleic acid
polymerization reactions may provide new tools in mole-
cular biology studies. However, thus far, the use of caged
nucleotides for controlled polymerization of nucleic acids
has not been reported.
Here, we describe the use of ATP caged with [7-(diethyl-
amino)coumarin-4-yl]methyl (DEACM) for light-
controlled in vitro transcription reactions (Figure 1).
Polymerization is blocked when DEACM is bonded to
the gamma phosphate group of the ATP molecule.
Controlled light irradiation releases ATP and transcription
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through visible light irradiation prevents UV-associated
nucleic acid and protein damage. In order to provide full
control over the process, conditions involved in substrate
release, nucleotide availability after release and the eﬀect
of the released coumarin in RNA polymerization were
assessed in further detail.
MATERIALS AND METHODS
Materials
All chemicals were purchased from Sigma-Aldrich,
St. Louis, MO, USA in the highest purity available and
used without further puriﬁcation. T7 RNA Polymerase
and Revert-Aid
TM M-MuLV Reverse Transcriptase were
purchased from Fermentas, Vilnius, Lithuania. DNase I
and SYBR GreenER Real-Time PCR Kit purchased
from Invitrogen, Karlsbad, CA, USA. All oligonucleo-
tides were purchased from STAB Vida, Portugal.
DEACM-ATP synthesis and purification
P3-[7-(dimethylamino)coumarin-4-yl]methyl adenosine
50-triphosphate trisodium salt (DEACM-ATP) was syn-
thesized as described by Geibler et al., method B (11).
A Hitachi-Merck HPLC L6200A Pump with an L-4500
Diode Array Detector using a Polystirene-Divinylbenzene
(PLRP-S, Polymer Labs, Darmstadt, Germany) column—
analytical column: 4.6 mm 15mm, 8mm, 300A ˚ ; semi-
preparative column: 7.4 mm 15mm, 8mm, 300A ˚ , was
employed for separation and puriﬁcation of DCEAM-
ATP. Eluent A was tributylammonium acetate buﬀer
in water, 5mM, pH 6.9; eluent B was methanol.
Semi-preparative gradient started with 20min at 30% of
B in A; with an increase to 100% B after 21min, and
ﬁnished after 26min at 100% of B. Separations were run
at a ﬂow rate of 3ml/min and the column temperature was
358C. After peak separation and collection, samples were
lyophilized, resuspended in water and stored in the dark at
 208C. A purity of >95% was determined by HPLC. All
solutions were protected from light and DEACM-ATP
manipulations were made in a dark chamber under red-
light illumination.
Photochemical andphotophysical studies
All spectroscopic measurements and irradiations were per-
formed in a 60ml quartz ﬂuorescence cuvette (0.3cm opti-
cal path) at 218C. Absorption spectra were recorded on a
Shimadzu UV-2501PC spectrophotometer. Fluorescence
measurements of aerated solutions were performed on a
Horiba-Jobin-Yvon SPEX Fluorolog 3.22 spectroﬂuori-
meter. All spectra collected with 1.5nm slit bandwidth
for excitation and emission, with correction ﬁles.
Fluorescence quantum yields (f) were determined by
the relative method versus coumarin 1 (7-diethylamino-
4-methylcoumarin) degassed solution in ethanol
(f=0.730) (17). The optical densities of DEACM-ATP,
7-diethylamino-4-hydroxymethylcoumarin (DEACM-
OH) solutions in water at pH 7.0 and that of the standard
were adjusted to identical values (0.08–0.12) at excitation
wavelength (386nm). Correction for the refractive index
was included in the calculation.
DEACM-ATP photochemical quantum yields (Chem),
deﬁned as the number of DEACM-OH molecules formed
by each photon absorbed by DEACM-ATP, were carried
Figure 1. Photolysis of DEACM-ATP and ATP release. (A) Structure of DEACM-ATP and respective photoproducts. After irradiation with 390nm
light, the ester bond between DEACM and ATP is cleaved, generating DEACM-OH and free ATP. (B) Representation of the light-controlled
transcription process. ATP (gray circle) is not available as substrate for transcription due to eﬃcient caging by DEACM (black ellipse). Irradiation
with visible light releases ATP (a) allowing transcription to be resumed (b), yielding full-length RNA products. RNA polymerase is represented by a
gray pacman.
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of DEACM-ATP solution (between 49 and 450mM)
were carried out and the resulting DEACM-OH deter-
mined by HPLC using a Polystirene-Divinylbenzene
(PLRP-S, Polymer Labs, Darmstadt, Germany) column
(4.6mm 15mm, 8mm, 300A ˚ ). Eluent A was tributylam-
monium acetate buﬀer in water, 5mM, pH 6.9; eluent B
was methanol. Eluent gradient started with 2min at 30%
of B in A, with an increase to 90% B after 2.5min, and
ﬁnished after 10min at 90% of B. Separations were run
at a ﬂow rate of 2ml/min, at 358C column tempera-
ture. Product separation was monitored at 380nm and
DEACM-OH (retention time=6.32min) concentration
determined by peak area quantiﬁcation. DEACM-OH
irradiations were carried out in a Horiba-Jobin-Yvon
Spex Fluorolog 1681 Spectrometer with a 450W xenon
arc lamp, monochromated for the excitation wavelength
(390nm, 18nm slit bandwidth). The actinometry of the
irradiation setup was performed with the concentrated
potassium ferrioxalate actinometer (18) and an intensity
of 1.36 10
 8 Einstein/min was measured. Photochemical
quantum yields were calculated as the slope of the linear
regression obtained by plotting DEACM-OH moles
formed (nDEACM-OH) as a function of irradiation time
(t), according to Equation (1).
nDEACM OH ¼chem   1   10 AT 
 
ADEACM ATP
AT

  t 1
The fraction of light absorbed by the solution (1   10
 AT)
was calculated from the absorption spectra. The fraction
of that light which was absorbed by DEACM-ATP
(ADEACM-ATP/AT) was derived from DEACM-OH and
DEACM-ATP concentrations as determined by HPLC
and their respective extinction coeﬃcients.
Transcription templatecloning and purification
A 110-bp fragment of Exon 7 of the human p53 gene
(TP53 tumor protein p53 [Homo sapiens], GenBank
accession no. X54156) was PCR ampliﬁed using primers
E7p53Fw: 50-gttggctctgactgtaccac-30 and E7p53Rev:
50-ctggagtcttccagtgtgatg-30. PCR ampliﬁcation was carried
out in 20ml using 0.5mM of primers, 0.2mM dNTPs with
0.5 U Taq DNA polymerase (Amersham Biosciences, GE
Healthcare, Europe, GmbH) on a Tpersonal Thermocycler
(Whatman Biometra, Germany). Following denaturation
at 958C for 5min, ampliﬁcation was performed for
25 cycles, each cycle consisting of 958C for 30s, annealing
at 548C for 30s, extension at 728C for 30s, with a ﬁnal
extension step at 728C for 5min. The resulting product
was re-ampliﬁed using a T7 promoter-E7p53Fw primer
(50-taatacgactcactatagggagagttggctctgactgtaccac-30)a n d
subsequently cloned in pJET1.2 (CloneJET
TM PCR
Cloning Kit, Fermentas, Vilnius, Lithuania) according to
manufacturer’s protocol. The resulting 133-bp fragment
was PCR ampliﬁed using primers E7p53Rev and T7
primer (50-taatacgactcactatagggaga-30) as described
above, puriﬁed through SureClean puriﬁcation kit
(Bioline, London, UK) and used as template for in vitro
transcription reactions. The cloned fragment was con-
ﬁrmed by direct sequencing using ABI Prism 3100 and
ABI Prism Big Dye technology (Applied Biosystems,
Foster, CA, USA).
Invitro transcription
Standard in vitro transcription using 100ng of tem-
plate was performed with 20 U of T7 RNA Polymerase
(Fermentas, Vilnius, Lithuania) according to the manufac-
turer’s protocol. Reactions were incubated 1h at 378C,
followed by heat inactivation of enzyme for 15min at
758C. DNA template digestion, ensuring absence of
DNA after transcription, was performed with 27 U of
DNase I (Invitrogen, Karlsbad, CA, USA) for 1h at
378C, which was subsequently heat inactivated for 15min
at 758C. In assays involving caged-ATP, ATP was
substituted by the equivalent amount of DEACM-ATP.
Products were analyzed on 3% agarose gel electrophore-
sis in 1 TBE buﬀer. The in vitro transcription reactions
with radiolabeled a-
32P-UTP (Perkin Elmer, 800Ci/ml,
10mCi/ml), followed the same procedure as described
earlier, to which 1.5mlo fa-
32P-UTP were added and reac-
tions incubated 1h at 378C. The resulting products were
denaturated for 2min at 758C and analyzed on a 6%
polyacrylamide/8M urea gel electrophoresis in 1 TBE.
Denaturing PAGE was run at 70W for 2h. Results were
visualized in an Optical Scanner Storm
TM 860 Instrument
(Molecular Dynamics, GE Healthcare, Europe, GmbH).
Reverse transcription (RT) andreal-time PCR reaction
RT was performed with Revert-Aid
TM M-MuLV Reverse
Transcriptase (Fermentas, Vilnius, Lithuania) according
to manufacturer’s speciﬁcations, using 0.25mMo f
E7p53Rev primer, annealing at 428C for 1h.
Real-time PCR assays were performed in a Corbett
Research Rotor-Gene RG3000 using SYBR GreenER
Real-Time PCR kit (Invitrogen, Karlsbad, CA, USA)
according to manufacturer’s speciﬁcations. Reactions were
performed in a total volume of 25mlw i t h0 . 5mM of primers
E7p53Fw and E7p53Rev. Following a preincubation at
508C for 2min and denaturation at 958C for 10min, Real-
time PCR was performed for 40 cycles, each cycle consisting
of 958C for 30s, annealing at 548C for 30s, extension at
728C for 30s, with a ﬁnal extension step at 728Cf o r5m i n .
RESULTS AND DISCUSSION
Photochemical properties
The photocleavage of DEACM-ATP upon irradiation at
390nm presents almost exclusively DEACM-OH and
ATP as products. The absorbed light promotes cleavage
of the C–O bond linking the 4-methyl group of 7-diethyl-
amino-4-methylcoumarin and the ATP phosphate ester
group, yielding free ATP and DEACM-OH after solvoly-
sis of the generated carbocation (3) (Figure 1). The
absorption and emission spectra of DEACM-ATP and
DEACM-OH are shown in Figure 2.
DEACM-ATP long-wavelength absorption band
( max=392nm, "max=17700/M/cm) presents a 7nm
red shift and a slightly higher extinction coeﬃcient with
respect to the alcohol (DEACM-OH,  max=385nm,
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other (coumarin-4-yl)methyl caged esters and corre-
sponding alcohols (19). The diﬀerences in absorption
between DEACM-ATP and DEACM-OH provide the
means for ATP release monitorization. Emission bands
present very close maxima, but DEACM-ATP ﬂuores-
cence intensity (ﬂuorescence quantum yield—f=0.166)
is larger than that found for DEACM-OH in water
(f=0.072). Absorption and emission bands of 7-amino-
coumarines are susceptible to medium polarity (20,21) and
while for in vitro applications, the solution polarity is
usually known, inside living cells signiﬁcant polarity dif-
ferences may occur and ﬂuorescence monitoring could be
compromised.
The proﬁle of ATP release with irradiation time (and
the eﬃciency of ATP release upon irradiation—Chem)
was measured in water pH 7.0 for diﬀerent concentrations
of caged ATP (Figure 3). The increase in caged nucleotide
concentration leads to a signiﬁcant decrease of the photo-
chemical yield. An important practical implication is that
for higher DEACM-ATP concentrations, longer irradia-
tion times are needed to attain the same fraction of free
ATP. For low concentrations of DEACM-ATP, quantita-
tive release of ATP can be attained in a few minutes (for
90% conversion, 10min irradiation of a 50mM solution or
15min for a 100mM solution). For higher concentrations
of DEACM-ATP, however, quantitative release of ATP is
time-consuming and the large irradiation times seriously
compromise biological applications.
This concentration quenching eﬀect is an important
drawback, for the reason that for quantitative release
with short irradiation times, very diluted solutions of
DEACM-ATP are necessary. This may originate some lim-
itations for in vitro application as higher concentrations
of nucleotides are usually needed to perform reactions.
In vitro transcription
For in vitro transcription, 50mM of a ribonucleotide mix
(CTP, UTP and GTP) was employed. In control samples,
absence of ATP impeded transcription (negative control)
and incubation with ATP (50mM) yielded a full-length
transcription product readily detected (positive control).
ATP was then substituted by DEACM-ATP and the mix-
ture submitted to several irradiation times (Figure 4A).
In the sample not subjected to irradiation no product for-
mation was observed, indicating DEACM eﬃcient caging
of ATP molecules blocking RNA polymerization. After
irradiation, full transcription product could be detected,
indicating that ATP had been released. The quantity of
transcript reaches its maximum with 5min of irradia-
tion and is signiﬁcantly lower than in the positive control,
even though DEACM-ATP and ATP concentration are
identical.
A gradual increase in product formation is observed
with increasing irradiation time (and consequently ATP
release) for concentrations up to 33mM of released ATP.
For higher concentrations, transcription is somehow
hampered. In order to assess whether the observed direct
relation between released ATP and transcription was asso-
ciated with formation of full-length transcript, sequential
concentrations of added ATP (Figure 4B) and released
ATP (resulting from increasing irradiation times of
DEACM-ATP, Figure 4C) were used in transcription reac-
tions, and analyzed by denaturing PAGE. These results
indicate that DEACM-ATP irradiation and photo-
released ATP yield full-length transcripts. Residual pro-
duct formation could be detected for the nonirradiated
sample, which is probably due to ambient light during
manipulation in transcription reactions. Even though
most sample handling was made in the dark chamber,
extra care must be taken during all procedure so as to
minimize unwanted release from precursor.
Further conﬁrmation that full-length transcripts were
attained was shown by RT–real-time PCR, which also
conﬁrmed product speciﬁcity and allowed for quantiﬁca-
tion. This step takes advantage of a sequence-speciﬁc
Figure 3. Irradiation proﬁles of four diﬀerent concentrations of
DEACM-ATP in water, pH 7.0. DEACM-OH molar fraction obtained
after discrete irradiation times with 390nm light were determined by
HPLC (see Materials and methods section). For each initial DEACM-
ATP concentration, the respective photochemical quantum yield is also
indicated.
Figure 2. Absorption and emission spectra of DEACM-ATP and
DEACM-OH. Measurements of DEACM-ATP (18.5mM, blue lines)
and DEACM-OH (20.8mM, red lines) were taken in water pH 7.0.
Absorption intensities are represented as extinction coeﬃcient as func-
tion of wavelength (full lines). Relative ﬂuorescence intensities with
excitation at 385nm (dashed lines) were corrected for respective absorp-
tions at excitation wavelength. Fluorescence quantum yields (f) for
both molecules are also indicated.
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to the RNA template produced, allowing for a clear dis-
tinction between residual nonspeciﬁc transcription and
full-length-speciﬁc products. The relative amount of initial
template in each sample was determined with relation to
the sample with the highest product quantity—25mMo f
released ATP (values obtained directly relate to quantities
generated in transcription), and the attained results can
be seen in Figure 5. Ampliﬁcation products were addition-
ally submitted to melting curve analysis and a dispersion
of <0.58C was obtained for the DEACM-ATP samples
(data not shown). Taken together, these results clearly
denote that speciﬁc full-length RNA is quantitatively
generated after ATP photo release. Once again, a direct
relation between transcript production and released ATP
occurs up to a certain concentration of ATP (ca. 25mM),
after which a decrease in product formation is observed.
The transcription assays show the presence of an inhi-
bitory eﬀect within the reaction, indicating that a photol-
ysis byproduct of DEACM-ATP irradiation interferes
with transcription. The cause of such hindrance seems to
be the DEACM-OH generated after DEACM-ATP
photocleavage. Clearly, DEACM-ATP does not impede
transcription as at maximal DEACM-ATP concentration
(before irradiation), residual transcription can still be
detected (Figure 4C). ATP released from caged-precursors
suﬀers no chemical alteration [see refs (11,19 and refer-
ences therein], which in the present case is evidenced by
successful initiation of transcription. Conversely, increas-
ing concentrations of DEACM-OH after a certain point
lead to decreasing transcription yields. For concentrations
above 100mM DEACM-OH, no transcript formation was
observed. This was conﬁrmed by performing control tran-
scription reactions with 50mM ATP to which increasing
amounts of DEACM-OH were added (Figure 6A). In
addition, ﬂuorescence spectra of DEACM-OH in the pres-
ence of T7 RNA polymerase show a 2nm red shift and a
20% decrease of intensity (Figure 6B), indicating that
DEACM-OH is in a diﬀerent environment (20,21). This
observation suggests a partition of DEACM-OH into the
protein, which might be responsible for enzyme inhibition
(20–24). No spectral interaction was observed between
template DNA and DEACM-OH. Also, DEACM-OH
presents a poor solubility in water (between 10
 4M and
10
 5M), which could be the reason for the observed parti-
tion and resulting inhibitory eﬀect over T7 RNA polymer-
ase. This inhibitory eﬀect of DEACM-OH limits the
concentration range of DEACM-ATP that can be used
for light-controlled in vitro transcription reactions.
CONCLUSIONS
We have successfully demonstrated the use of ATP caged
with DEACM for light-controlled in vitro transcription
Figure 4. In vitro transcription using DEACM-ATP. (A) Agarose gel
electrophoresis of in vitro transcription reaction with 50mM of CTP,
GTP and UTP. Positive control—transcription with 50mM ATP.
Negative control—transcription in absence of ATP. Irradiated
samples—transcription containing 50mM of DEACM-ATP before irra-
diation; duration of irradiation with 390nm visible light is indicated
for each sample: 0min (nonirradiated), 2min, 5min and 35min.
(B) Denaturing PAGE analysis of in vitro transcription reaction with
50mM of CTP, GTP and a-
32P-UTP. Increasing ATP concentrations
were employed for each sample, ranging from 0mM (right lane) to
50mM (left lane). (C) Denaturing PAGE analysis of in vitro transcription
reaction with 50mM of CTP, GTP, a-
32P-UTP and DEACM-ATP. Each
sample was subjected to increasing irradiation times, from 0min (right
lane) to 35min (left lane). Released ATP concentrations estimated by
HPLC (see Materials and methods section).
Figure 5. Relative quantiﬁcation of full-length transcription products as
function of ATP released after DEACM-ATP irradiation. Transcript
quantiﬁcation by RT–real-time PCR as function of estimated released-
ATP. Relative product quantity was normalized in relation to the
sample showing the highest product quantity (25mM ATP) (see
Materials and methods section).
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eﬃciently impede transcription. Upon irradiation, ATP is
released and the transcription reaction resumes, yielding
full-length RNA products. The release of ATP is concen-
tration dependent, with the photochemical quantum yield
quenched for high concentrations of DEACM-ATP.
Higher concentrations of caged-ATP signiﬁcantly increase
the irradiation times needed for complete photolysis. The
released byproduct, DEACM-OH, seems to inhibit in vitro
transcription for concentrations higher than 25mM, prob-
ably due to the partition of DEACM-OH into the protein,
evidenced by the red shift and concomitant decrease in
intensity of the ﬂuorescence spectra of DEACM-OH in
presence of T7 RNA polymerase. The nature of interac-
tion between DEACM-OH and T7 RNA polymerase, and
possible inhibition mechanisms still require further
clariﬁcation.
To our knowledge, this is the ﬁrst time that photo
manipulation of nucleic acids polymerization is described.
Furthermore, polymerization control was accomplished
through visible light irradiation, thus preventing UV-asso-
ciated nucleic acid and protein damage incompatible with
potential biotechnological applications.
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